Novartis AG (NVS) stock forecast for 2026

The forecast has been updated: June 29, 2022 14:05


Novartis AG stock price online today

Analyst Target Price

104.4

Dividend Date

17.03.2022

Ex Dividend Date

08.03.2022

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Novartis AG stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? Novartis AG stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $104.4 target price for Novartis AG stock stock.

Today 200 Day Moving Average is the support level (85.61 $).

50 Day Moving Average is the support level (87.37 $).




NVS Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 95.35 93.25 97.06 3.93 %
Mar 93.59 90.78 95.02 4.45 %
Mar 95.88 93.61 96.91 3.40 %
Apr 96.60 93.55 99.04 5.54 %
May 94.79 92.59 96.84 4.39 %
Jun 97.14 96.05 99.59 3.55 %
Jul 95.20 92.57 97.71 5.26 %
Aug 95.88 93.70 96.96 3.36 %
Sep 99.10 97.80 101.80 3.93 %
Oct 100.41 98.00 101.66 3.60 %
Nov 98.89 97.58 101.69 4.05 %
Dec 96.63 95.24 99.61 4.38 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Novartis AG stock.


Novartis AG overview

Novartis AG Address

LICHTSTRASSE 35, BASEL, CH

Market Capitalization

190 147 969 000 $

EBITDA

17 967 000 000

PE Ratio

7.95

PEG Ratio

3.876

Dividend Per Share

3.39

Dividend Yield

0.041

EPS

10.73

Quarterly Earnings Growth YOY

0.088

Quarterly Revenue Growth YOY

0.009

Trailing PE

7.95

Forward PE

13.11

EV To Revenue

3.638

EV To EBITDA

5.85

52 Week High

94.26

52 Week Low

76.15

50 Day Moving Average

87.37

200 Day Moving Average

85.61

Shares Outstanding

2212600000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Novartis AG stock forecast for this year


Novartis AG stock forecast for Jan 2026.
Estimated Average Forecasted Novartis AG Price: 95.35. Negative monthly dynamics of the instrument is expected with 3.929% volatility is expected.

Pessimistic forecast: 93.25

Optimistic: 97.06


Novartis AG stock forecast for Mar 2026.
Estimated Average Forecasted Novartis AG Price: 93.59. Negative monthly dynamics of the instrument is expected with 4.452% volatility is expected.

Pessimistic forecast: 90.78

Optimistic: 95.02


Novartis AG stock forecast for Mar 2026.
Estimated Average Forecasted Novartis AG Price: 95.88. Positive monthly dynamics of the instrument is expected with 3.403% volatility is expected.

Pessimistic forecast: 93.61

Optimistic: 96.91


Novartis AG stock forecast for Apr 2026.
Estimated Average Forecasted Novartis AG Price: 96.60. Positive monthly dynamics of the instrument is expected with 5.540% volatility is expected.

Pessimistic forecast: 93.55

Optimistic: 99.04


Novartis AG stock forecast for May 2026.
Estimated Average Forecasted Novartis AG Price: 94.79. Negative monthly dynamics of the instrument is expected with 4.385% volatility is expected.

Pessimistic forecast: 92.59

Optimistic: 96.84


Novartis AG stock forecast for Jun 2026.
Estimated Average Forecasted Novartis AG Price: 97.14. Positive monthly dynamics of the instrument is expected with 3.551% volatility is expected.

Pessimistic forecast: 96.05

Optimistic: 99.59


Novartis AG stock forecast for Jul 2026.
Estimated Average Forecasted Novartis AG Price: 95.20. Negative monthly dynamics of the instrument is expected with 5.261% volatility is expected.

Pessimistic forecast: 92.57

Optimistic: 97.71


Novartis AG stock forecast for Aug 2026.
Estimated Average Forecasted Novartis AG Price: 95.88. Positive monthly dynamics of the instrument is expected with 3.362% volatility is expected.

Pessimistic forecast: 93.70

Optimistic: 96.96


Novartis AG stock forecast for Sep 2026.
Estimated Average Forecasted Novartis AG Price: 99.10. Positive monthly dynamics of the instrument is expected with 3.933% volatility is expected.

Pessimistic forecast: 97.80

Optimistic: 101.80


Novartis AG stock forecast for Oct 2026.
Estimated Average Forecasted Novartis AG Price: 100.41. Positive monthly dynamics of the instrument is expected with 3.595% volatility is expected.

Pessimistic forecast: 98.00

Optimistic: 101.66


Novartis AG stock forecast for Nov 2026.
Estimated Average Forecasted Novartis AG Price: 98.89. Negative monthly dynamics of the instrument is expected with 4.045% volatility is expected.

Pessimistic forecast: 97.58

Optimistic: 101.69


Novartis AG stock forecast for Dec 2026.
Estimated Average Forecasted Novartis AG Price: 96.63. Negative monthly dynamics of the instrument is expected with 4.385% volatility is expected.

Pessimistic forecast: 95.24

Optimistic: 99.61



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 109.1 (29.06.2022) 1.99 %
AbbVie Inc.
ABBV 154.14 (29.06.2022) 1.08 %
Aeterna Zentaris Inc.
AEZS 0.1801 (28.06.2022) -5.51 %
Allakos Inc.
ALLK 3.32 (29.06.2022) 2.79 %
Allogene Therapeutics, Inc.
ALLO 11.68 (29.06.2022) 1.74 %
Amgen Inc.
AMGN 245.43 (29.06.2022) 0.79 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 7.58 (29.06.2022) 15.73 %
Aurora Cannabis Inc.
ACB 1.37 (29.06.2022) -8.05 %
Becton Dickinson and Company
BDX 249.34 (29.06.2022) 1.97 %
Biogen Inc.
BIIB 205.23 (29.06.2022) 1.34 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 145.65 (29.06.2022) 0.85 %
BioNTech SE
BNTX 141.98 (29.06.2022) 1.54 %
bluebird bio, Inc.
BLUE 4.58 (29.06.2022) 13.37 %
Boston Scientific Corp.
BSX 37.8 (29.06.2022) 0.80 %
Bristol-Myers Squibb Company
BMY 78.28 (29.06.2022) -0.53 %
Canopy Growth Corp.
CGC 3.5 (29.06.2022) -3.05 %
Castle Biosciences, Inc.
CSTL 23.01 (29.06.2022) 0.13 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 30.53 (29.06.2022) -2.30 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 5.09 (29.06.2022) -1.74 %
Gilead Sciences, Inc.
GILD 62.48 (29.06.2022) 0.43 %
GlaxoSmithKline plc
GSK 43.77 (29.06.2022) 0.97 %
GoodRx Holdings, Inc.
GDRX 6.3 (29.06.2022) -3.96 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.89 (29.06.2022) 0.34 %
Inovio Pharmaceuticals, Inc.
INO 1.79 (29.06.2022) -1.65 %
Johnson & Johnson
JNJ 176.99 (29.06.2022) 0.03 %
Medtronic plc.
MDT 90.42 (29.06.2022) 1.37 %
Merck & Co., Inc.
MRK 92.51 (29.06.2022) 0.67 %
Moderna, Inc.
MRNA 142.81 (29.06.2022) 0.44 %
Novartis AG
NVS 84.77 (29.06.2022) 0.71 %
Novavax, Inc.
NVAX 51.85 (29.06.2022) 1.55 %
ObsEva SA
OBSV 1.72 (28.06.2022) -2.82 %
OrganiGram Holdings Inc.
OGI 0.97 (29.06.2022) -3.96 %
Pfizer Inc.
PFE 50.94 (29.06.2022) 0.55 %
Regeneron Pharmaceuticals, Inc.
REGN 597.62 (29.06.2022) 0.54 %
Sanofi
SNY 52.67 (29.06.2022) 1.02 %
Schrodinger, Inc.
SDGR 27.55 (29.06.2022) -1.15 %
Senseonics Holdings, Inc.
SENS 1.01 (29.06.2022) 0.00 %
Sorrento Therapeutics, Inc.
SRNE 1.96 (28.06.2022) -3.45 %
Stryker Corp.
SYK 199.43 (29.06.2022) 0.82 %
Sundial Growers Inc.
SNDL 0.3412 (29.06.2022) -6.98 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.95 (29.06.2022) 1.53 %
Thermo Fisher Scientific Inc.
TMO 535.92 (29.06.2022) 0.03 %
Tilray, Inc.
TLRY 3.31 (29.06.2022) -3.78 %
UnitedHealth Group, Inc.
UNH 515.71 (29.06.2022) 1.43 %
Veeva Systems Inc.
VEEV 199.74 (29.06.2022) -0.38 %
Zomedica Corp.
ZOM 0.2207 (29.06.2022) -12.73 %
Zynerba Pharmaceuticals, Inc.
ZYNE 1.15 (29.06.2022) -6.50 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.